1. Lipid Nanoparticles Decorated with TNF-Related Aptosis-Inducing Ligand (TRAIL) Are More Cytotoxic than Soluble Recombinant TRAIL in Sarcoma
   Ana Gallego-Lleyda et al, 2018, International Journal of Molecular Sciences CrossRef
2. Two-dimensional gel electrophoresis analysis of the leiomyoma interstitial fluid reveals altered protein expression with a possible involvement in pathogenesis
   BLENDI URA et al, 2015, Oncology Reports CrossRef
3. Evaluation of the safety and efficacy of TRAIL and taurolidine use on human fibrosarcoma xenografts in vivo
   KAMRAN HARATI et al, 2016, Oncology Letters CrossRef
4. Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib
   Michael J. Böhm et al, 2019, Sarcoma CrossRef
5. Short-term treatment with taurolidine is associated with liver injury
   René Fahrner et al, 2017, BMC Pharmacology and Toxicology CrossRef
6. Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma
   Lucy Swift et al, 2020, Investigational New Drugs CrossRef
7. The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy
   Santiago Rello-Varona et al, 2015, Frontiers in Oncology CrossRef
8. Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation
   Mario Jiménez Hernández et al, 2021, The Journal of Vascular Access CrossRef
9. Curcumin and Viscum album Extract Decrease Proliferation and Cell Viability of Soft-Tissue Sarcoma Cells: An In Vitro Analysis of Eight Cell Lines Using Real-Time Monitoring and Colorimetric Assays
   K. Harati et al, 2017, Nutrition and Cancer CrossRef